We are proud to announce a 100% vaccination rate of all providers and staff at PCC!

Open Trials at PCC

Available Clinical Trials at Pacific Cancer Care

Pacific Cancer Care is driven by a vision to be the leader for the treatment of cancer in the Monterey County. Our clinicians and investigators identify and conduct Phase I-IV treatment options that are new and innovative, and that will positively impact our patients. Below is a list of clinical trials currently available at Pacific Cancer Care.

For more information regarding clinical trial opportunities, please contact us at (831) 375-4105.

Advanced Unresectable or Metastatic Solid Malignancy
NCT #04632992
MyTACTIC: An Open-Label Phase II Study Evaluating Targeted Therapies in Patients Who Have Advanced Solid Tumors With Genomic Alterations Or Protein Expression Patterns Predictive or Response

Breast Cancer
NCT #04895358
Keynote-B49: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) in locally recurrent inoperable or Metastatic Breast Cancer

Head and Neck Squamous Cell Carcinoma
NCT #04338399
BURAN: Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Hematologic Malignancies
NCT #03598608
MK4280-003: A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab in Participants with Hematologic Malignancies

Hematologic Malignancies
NCT #03893682
APTOSE: Phase 1 a/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients with CLL/SLL or Non-Hodgkin’s Lymphomas

Precision Medicine
NCT #04843332
Reducing Cancer Disparities Through Innovative Community-Academic Partnership to Advance Access and Delivery of Precision Medicine in Monterey County

The Alcance Study- English

The Alcance Study- Spanish

Ovarian Cancer
NCT# 05116189
MK3475-B96: A Phase 3 Study of Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

Prostate Cancer
NCT# 03706365
JPCM: A Phase 2/3 Study of Abiraterone Plus Prednisone With or Without Abemaciclib (LY2835219 in Participants with Prostate Cancer

Through partnerships with organizations such as the Dana Farber Cancer Institute and Parker Institute for Cancer Immunotherapy, our patients rest assured knowing that a full complement of research and clinical resources are available to them, all synchronized and supervised by their Pacific Cancer Care team.